Gastrointestinal Cancer News

Molecular profiling of solid tumors in children and young adults has a significant impact on diagnosis and treatment recommendations, according to results of an interim analysis presented during the virtual ASCO Annual Meeting.

Thirty-four physicians have received Fellow of the American Society of Clinical Oncology distinction.

IACS-6274, a selective glutaminase-1 inhibitor, appeared safe and demonstrated antitumor activity among patients with biomarker-selected advanced solid tumors, according to phase 1 study results presented at the virtual ASCO Annual Meeting.

The addition of nivolumab to chemotherapy or ipilimumab significantly improved OS compared with chemotherapy alone among patients with previously untreated advanced esophageal squamous cell carcinoma, according to phase 3 study findings.

Higher red blood cell transfusion rates correlated with higher odds for morbidity and mortality among patients who underwent elective GI cancer resection, according to a presentation at Digestive Disease Week.

Multi-target stool DNA screening tests predicted neoplasia at follow-up colonoscopy more often than fecal immunochemical test or colonoscopy alone, according to a presentation at Digestive Disease Week.

Endoscopy in patients aged younger than 50 years decreased the incidence of colorectal cancer, according to study estimates reported at Digestive Disease Week.

The FDA granted accelerated approval to infigratinib for previously treated locally advanced or metastatic cholangiocarcinoma that harbors FGFR2 fusion or rearrangement.

Primary care practitioners need increased education and recommendations for early-onset colorectal cancer screening practices, according to a presentation at Digestive Disease Week.

Researchers found higher rates of colorectal neoplasia correlated with male sex and increased age, according to a presentation at Digestive Disease Week.